MitoImmune Therapeutics Inc. is a drug discovery and development biotech company that harnesses the power of mitochondria and its proprietary technology targeting mitochondria as the source for developing new potential breakthrough therapeutics. Our mission is to increase healthy lifespan by developing treatments for mitochondrial dysfunction-related necrotic and inflammatory diseases.
Founded in August 2018, the company’s ...
MitoImmune Therapeutics Inc. is a drug discovery and development biotech company that harnesses the power of mitochondria and its proprietary technology targeting mitochondria as the source for developing new potential breakthrough therapeutics. Our mission is to increase healthy lifespan by developing treatments for mitochondrial dysfunction-related necrotic and inflammatory diseases.
Founded in August 2018, the company’s lead program is based on the breakthrough scientific findings of its founder Soon Ha Kim at LG Life Sciences which was acquired by LG Chem in the end of 2017.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.